Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Similar documents
Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Package leaflet: Information for the user. Carmellose sodium

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. SIMBRINZA 10 mg/ml + 2 mg/ml eye drops, suspension Brinzolamide/brimonidine tartrate

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

PATIENT INFORMATION LEAFLET

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

NEVANAC TM 0.1% Eye Drops

PATIENT INFORMATION LEAFLET

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

Package leaflet: Information for the user

Package leaflet: Information for the patient

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

1 What Flixonase is and what it is used for

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

1. What Faslodex is and what it is used for

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

1. What Octostim Nasal Spray is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

BrinzoQuin Eye Drops 1.0%

Package leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the patient

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

ACULAR EYE DROPS 5 mg/ml Eye Drops

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Package leaflet: Information for the patient

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

ZADITEN Eye Drops 1.0%

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Beclometasone dipropionate

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package Leaflet: Information for the user

Package leaflet: Information for the user

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

VOLTAREN OPHTHA Eye Drops 0.1%

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

Package leaflet: Information for the user. Tremfya 100 mg solution for injection in pre-filled syringe guselkumab

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient. Latanoprost 50 micrograms/ml eye drops, solution latanoprost

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Package leaflet: Information for the user. Qutenza 179 mg cutaneous patch capsaicin

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

1. What Ursofalk 250mg hard capsules are and what they are used for

TOBRADEX TM Eye Drops

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

Transcription:

Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What NEVANAC is and what it is used for 2. What you need to know before you use NEVANAC 3. How to use NEVANAC 4. Possible side effects 5. How to store NEVANAC 6. Contents of the pack and other information 1. What NEVANAC is and what it is used for NEVANAC contains the active substance nepafenac, and belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). NEVANAC is to be used by adults: - to prevent and relieve eye pain and inflammation following cataract surgery on the eye - to reduce the risk of macular oedema (swelling in the back of the eye) following cataract surgery on the eye in diabetic patients. 2. What you need to know before you use NEVANAC Do not use NEVANAC - if you are allergic to nepafenac or any of the other ingredients of this medicine (listed in section 6), - if you are allergic to other nonsteroidal anti-inflammatory drugs (NSAID) - if you have experienced asthma, skin allergy, or intense inflammation in your nose when using other NSAIDs. Examples of NSAIDs are: acetylsalicylic acid, ibuprofen, ketoprofen, piroxicam, diclofenac. Warnings and precautions Talk to your doctor, pharmacist or nurse before using NEVANAC: - if you bruise easily or have bleeding problems or have had them in the past. - if you have any other eye disorder (e.g. an eye infection) or if you are using other medicines in the eye (especially topical steroids). - if you have diabetes. - if you have rheumatoid arthritis. - if you have had repeated eye surgery within a short period of time. Avoid sunlight during treatment with NEVANAC 1

Wearing contact lenses is not recommended after cataract surgery. Your doctor will advise you when you can use contact lenses again (see also NEVANAC contains benzalkonium chloride ) Children and adolescents Do not give this medicine to children and adolescents below 18 years old because the safety and efficacy in this population has not been established. Other medicines and NEVANAC Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. NEVANAC can affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma. Also tell your doctor if you are taking medicines that reduce blood clotting (warfarin) or other NSAIDs. They may increase the risk of bleeding. Pregnancy and breast-feeding If you are pregnant, or might get pregnant, talk to your doctor before you use NEVANAC. Women who may become pregnant are advised to use effective contraception during NEVANAC treatment. The use of NEVANAC is not recommended during pregnancy. Do not use NEVANAC unless clearly indicated by your doctor. If you are breast-feeding, NEVANAC may pass into your milk. However, no effects on suckling children are anticipated. NEVANAC can be used during breastfeeding. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines Do not drive or use machines until your vision is clear. You may find that your vision is blurred for a time just after using NEVANAC. NEVANAC contains benzalkonium chloride The preservative in NEVANAC, bezalkonium chloride, can discolour soft lenses and may cause eye irritation and corneal side effects (eye surface problems). If your doctor informs you that you can use contact lenses again, please note that you should remove them prior to application and wait at least 15 minutes before reinsertion. 3. How to use NEVANAC Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Only use NEVANAC for your eyes. Do not swallow or inject. The recommended dose is One drop in the affected eye or eyes, three times a day - morning, midday, and evening. Use at the same time each day. 2

When to take and for how long Begin 1 day before cataract surgery. Continue on the day of surgery. Then use it for as long as your doctor tells you to. This may be up to 3 weeks (to prevent and relieve eye pain and inflammation) or 60 days (to prevent the development of macular oedema) after your operation. How to use Wash your hands before you start. 1 2 Shake well before use. Twist off the bottle cap. After cap is removed, if tamper evident snap collar is loose, remove before using product. Hold the bottle, pointing down, between your thumb and fingers. Tilt your head back. Pull down your lower eyelid with a clean finger, until there is a pocket between the eyelid and your eye. The drop will go in here (picture 1). Bring the bottle tip close to the eye. Do this in front of a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. Gently press on the base of the bottle to release one drop of NEVANAC at a time. Do not squeeze the bottle: it is designed so that a gentle press on the bottom is all that it needs (picture 2). If you use drops in both eyes, repeat the steps for your other eye. Close the bottle cap firmly immediately after use. If a drop misses your eye, try again. If you are using other eye drops, wait at least five minutes between using NEVANAC and the other drops. If you use more NEVANAC than you should Rinse your eye out with warm water. Do not put in any more drops until it is time for your next regular dose. If you forget to use NEVANAC Use a single dose as soon as you remember. If it is almost time for the next dose, leave out the missed dose and continue with the next dose of your regular routine. Do not use a double dose to make up for a missed dose. Do not use more than one drop in the affected eye(s) 3 times daily. If you stop using NEVANAC Do not stop using NEVANAC without speaking to your doctor first. You can usually carry on using the drops, unless you experience serious side effects. If you are worried talk to your doctor or pharmacist. If you have any further questions on the use of this medicine ask your doctor, pharmacist or nurse. 3

4. Possible side effects Like all medicines, this medicine can cause side effects although not everybody gets them. There may be a higher risk of corneal side effects (eye surface problems) if you have: - complicated eye surgery - repeated eye surgery within a short period of time - certain disorders of the surface of the eye, such as inflammation or dry eye - certain general disease, such as diabetes or rheumatoid arthritis Contact your doctor immediately if your eyes become more red or more painful whilst using the drops. This may be a result of inflammation on the eye surface with or without loss or damage of cells or an inflammation of the coloured part of the eye (iritis). These side effects have been observed in up to 1 in 100 people. The following side effects have also been observed with NEVANAC 1 mg/ml eye drops, suspension or NEVANAC 3 mg/ml eye drops, suspension, or both. Uncommon side effects (may affect up to 1 in 100 people) Effects in the eye: eye surface inflammation with or without loss or damage of cells, foreign body sensation in the eyes, eyelid crusting or drooping. Rare side effects (may affect up to 1 in 1,000 people) Effects in the eye: iris inflammation, eye pain, eye discomfort, dry eye, eyelid swelling, eye irritation, itchy eye, eye discharge, allergic conjunctivitis (eye allergy), increased tear production, deposits on the eye surface, fluid or swelling at the back of the eye, eye redness. General side effects: dizziness, headache, allergic symptoms (eyelid allergic swelling), nausea, skin inflammation, redness and itching. Side effects with frequency not known (cannot be estimated from the available data) Effects in the eye: damage on the surface of the eye such as thinning or perforation, impaired healing of the eye, eye surface scar, clouding, reduced vision, eye swelling, blurred vision. General side effects: vomiting, increased blood pressure. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard 4

Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie Malta ADR Reporting Website: www.medicinesauthority.gov.mt/adrportal 5. How to store NEVANAC Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and the carton after EXP. The expiry date refers to the last day of that month. Do not store above 30 C. Throw away the bottle 4 weeks after first opening, to prevent infections. Write the date of opening on the bottle and carton label in the space provided. Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What NEVANAC contains The active substance is nepafenac. One ml of suspension contains 1 mg of nepafenac. The other ingredients are benzalkonium chloride (see section 2), carbomer, disodium edetate, mannitol, purified water, sodium-chloride and tyloxapol. Tiny amounts of sodium hydroxide and/or hydrochloric acid are added to keep acidity levels (ph levels) normal. What NEVANAC looks like and the contents of the pack NEVANAC is a liquid (light yellow to light orange suspension) supplied in a pack containing one 5 ml plastic bottle with a screw cap. Marketing Authorisation Holder Novartis Europharm Limited Frimley Business Park Camberley GU16 7SR United Kingdom. Manufacturer S.A. Alcon Couvreur N.V Rijksweg 14 B-2870 Puurs Belgium 5

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. Ireland United Kingdom Novartis Ireland Limited Novartis Pharmaceuticals UK Ltd. Tel: +353 1 260 12 55 Tel: +44 1276 698370 Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 This leaflet was last revised in 05/2017 Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu 6